Objective: We compared the pharmacokinetics of two methods for dosing gentamicin for the treatment of postpartum endometritis with the goal of achieving adequate peak serum concentrations (>12 mg/L) and prolonged trough levels below 2 mg/L.
minoglycosides in combination with ampicillin, clindamycin, or metronidazole represent a cost-effective treatment for postpartum endometritis, provided excessive serum concentration monitoring and nephrotoxicity do not occur. Traditionally, peak concentrations of aminoglycosides >6.0 mg/L have been associated with efficacy, and trough concentrations <2.0 mg/L have been associated with decreased toxicity. 2 Administering aminoglycosides as single, large, daily doses takes advantage of several pharmacokinetic (i.e., concentration-dependent killing activity) and pharmacodynamic (i.e., postantibiotic effect) properties. patients receiving aminoglycosides. Major risk factors for developing nephrotoxicity include older age, multisystem disease, preexisting renal disease (estimated by a creatinine clearance <60 mL/min), and concomitant administration of nephrotoxic drugs. 4 Once-daily dosing has demonstrated equal efficacy and toxicity when compared with conventional dosing for many serious infections. 1 Exclusion criteria included renal dysfunction (creatinine clearance < 50 mL/min), history of ototoxicity or nephrotoxicity due to aminoglycosides, and age <16 years. All doses were infused over 60 min.
All patients were monitored daily by the respective hospital pharmacy pharmacokinetic services. Blood samples for drug concentrations were drawn by venipuncture after the second dose. Peak concentration was drawn hr following end of infusion, and a midpoint concentration was drawn [8] [9] [10] [11] [12] 
RESULTS
Five patients were studied using weight-based calculations, and 17 were studied using standard pharmacokinetic equations. The weight-based method achieved adequate peak concentrations, although 40% of our study patients had peaks in excess of 20 mg/L. In the Del Priore et al. 9 study, in which the same 5-mg/kg calculation was used, the investigators reported peak concentrations (16.6 mg/L) similar to those in our study, but did not indicate the number of subjects with peak levels >20 mg/L.
The formula-based method resulted in 76% of patients reaching peak concentrations below our target of 12 mg/L. Of note, all of these patients would have been considered successes in the Del Priore et al. 9 study, since the target peak concentration in that study was >5 mg/L. Although the general literature acknowledges that the lower peak concentration is acceptable for gentamicin dosing, higher values provide an increased likelihood of organism susceptibility. Also of interest is the fact that we used the well accepted volume of distribution of 0.35 L/kg in our formula-based calculation, 9 whereas the actual calculated mean value for the group was 0.43 L/kg. 
